Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting. | Front Mol Biosci | 2022 | 35359592 | PubTator, text mining | PubMed |
| Evaluation of Four Biomarkers in Patients Chronically Infected with Trypanosoma cruzi and Their Relationship with Disease Progression. | Am J Trop Med Hyg | 2022 | 35344933 | PubTator, text mining | PubMed |
| Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. | J Hematol Oncol | 2022 | 35331296 | PubTator, text mining | PubMed |
| Proteomic Alterations in Follicular Fluid of Human Small Antral Follicles Collected from Polycystic Ovaries-A Pilot Study. | Life (Basel) | 2022 | 35330141 | PubTator, text mining | PubMed |
| Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease. | Biomedicines | 2022 | 35327498 | PubTator, text mining | PubMed |
| Comprehensive Analyses of Bone and Cartilage Transcriptomes Evince Ion Transport, Inflammation and Cartilage Development-Related Genes Involved in Chickens' Femoral Head Separation. | Animals (Basel) | 2022 | 35327184 | PubTator, text mining | PubMed |
| Stiffness- and Bioactive Factor-Mediated Protection of Self-Assembled Cartilage against Macrophage Challenge in a Novel Co-Culture System. | Cartilage | 2022 | 35313741 | PubTator, text mining | PubMed |
| Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. | Front Oncol | 2022 | 35311155 | PubTator, text mining | PubMed |
| Deficiency of Integrin β4 Results in Increased Lung Tissue Stiffness and Responds to Substrate Stiffness via Modulating RhoA Activity. | Front Cell Dev Biol | 2022 | 35309934 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Derived miR-105-5p Promotes Malignant Phenotypes of Esophageal Squamous Cell Carcinoma by Targeting SPARCL1 via FAK/AKT Signaling Pathway. | Front Genet | 2022 | 35309127 | PubTator, text mining | PubMed |
| Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma. | Front Oncol | 2022 | 35299749 | PubTator, text mining | PubMed |
| The possible role of hypoxia in the affected tissue of relapsed clubfoot. | Sci Rep | 2022 | 35292718 | PubTator, text mining | PubMed |
| Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies. | Neurotherapeutics | 2022 | 35290608 | PubTator, text mining | PubMed |
| Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes. | J Cell Physiol | 2022 | 35285015 | PubTator, text mining | PubMed |
| Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review. | Ann Transl Med | 2022 | 35282052 | PubTator, text mining | PubMed |
| HucMSCs-exosomes containing miR-21 promoted estrogen production in ovarian granulosa cells via LATS1-mediated phosphorylation of LOXL2 and YAP. | Gen Comp Endocrinol | 2022 | 35271888 | PubTator, text mining | PubMed |
| Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival. | Cancers (Basel) | 2022 | 35267510 | PubTator, text mining | PubMed |
| Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis. | Front Pharmacol | 2022 | 35250597 | PubTator, text mining | PubMed |
| Increased serum LOXL2 concentration in pelvic inflammatory disease with pelvic adhesion. | BMC Womens Health | 2022 | 35246120 | PubTator, text mining | PubMed |
| 3D Printing for Bone-Cartilage Interface Regeneration. | Front Bioeng Biotechnol | 2022 | 35237582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=41